Is CV Sciences (CV Sciences) a good value stock to buy?
Only 0.02% of the stock of CV Sciences is held by institutions. Earnings for CV Sciences are expected to remain at ($0.09) per share in the coming year. The P/E ratio of CV Sciences is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
How much money does CV sciences make?
CV Sciences has a market capitalization of $16.77 million and generates $24.43 million in revenue each year. The company earns $-22.28 million in net income (profit) each year or ($0.15) on an earnings per share basis. How many employees does CV Sciences have?
Who is the founder of CV Sciences?
The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, CA. Will CV Sciences, Inc. (CVSI) Report Negative Q3 Earnings?
Where can I buy shares of cvsi?
Shares of CVSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
See more
Is CV Sciences a good stock to buy?
If you are looking for stocks with good return, CV Sciences Inc stock can be a bad, high-risk 1-year investment option. CV Sciences Inc real time quote is equal to 0.040 USD at 2022-06-01, but your current investment may be devalued in the future.
What happened with CV sciences?
CV Sciences had negative adjusted EBITDA for fiscal 2021 of $10 million, compared to negative adjusted EBITDA of $12 million in 2020. Despite a challenging 2021, the company did increase its retail distribution from 7,300 stores as of December 31, 2020, to more than 8,400 stores as of December 31, 2021.
Should I buy or sell CV Sciences stock right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CV Sciences in the last year. There are currently 2 hold ratings...
What is CV Sciences' stock price forecast for 2022?
2 brokerages have issued 1-year price targets for CV Sciences' stock. Their CVSI stock forecasts range from $0.17 to $0.17. On average, they antici...
How has CV Sciences' stock performed in 2022?
CV Sciences' stock was trading at $0.12 at the start of the year. Since then, CVSI shares have decreased by 62.5% and is now trading at $0.0450. V...
How were CV Sciences' earnings last quarter?
CV Sciences, Inc. (OTCMKTS:CVSI) issued its quarterly earnings results on Monday, May, 16th. The company reported ($0.02) EPS for the quarter, meet...
Who are CV Sciences' key executives?
CV Sciences' management team includes the following people: Mr. Joseph D. Dowling , CEO, Sec. & Director (Age 65, Pay $418.52k) Mr. Joerg Grasse...
Who are some of CV Sciences' key competitors?
Some companies that are related to CV Sciences include RegeneRx Biopharmaceuticals (RGRX) , Lotus Pharmaceuticals (LTUS) , Emerald Bioscience (E...
What other stocks do shareholders of CV Sciences own?
Based on aggregate information from My MarketBeat watchlists, some companies that other CV Sciences investors own include (CGC) , Aurora Cannabi...
What is CV Sciences' stock symbol?
CV Sciences trades on the OTCMKTS under the ticker symbol "CVSI."
How do I buy shares of CV Sciences?
Shares of CVSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
About CV Sciences
Headlines
CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand.
CV Sciences (OTCMKTS:CVSI) Frequently Asked Questions
Is Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC
